Marked elevation of serum lactate dehydrogenase in primary myelofibrosis: clinical and prognostic correlates

Blood Cancer J. 2017 Dec 18;7(12):657. doi: 10.1038/s41408-017-0024-9.

Authors

Sahrish Shah¹, Mythri Mudireddy¹, Curtis A Hanson², Rhett P Ketterling², Naseema Gangat¹, Animesh Pardanani¹, Ayalew Tefferi³

Affiliations

¹ Division of Hematology, Department of Internal and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.
² Division of Hematopathology, Department of Internal and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.
³ Division of Hematology, Department of Internal and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA. tefferi.ayalew@mayo.edu.

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Female
Humans
L-Lactate Dehydrogenase / blood*
Male
Middle Aged
Primary Myelofibrosis / blood*
Primary Myelofibrosis / enzymology*
Primary Myelofibrosis / mortality
Prognosis
Survival Analysis

Substances

L-Lactate Dehydrogenase